1093 — CSPC PHARMACEUTICAL Share News
0.000.00%
Last trade - 00:00- HK$96.15bn
- HK$77.27bn
- CNY26.01bn
Brief: CSPC Pharmaceutical Initiates Phase I Clinical Trial Of SYH2092 Injection
Brief: Cspc Pharmaceutical Says Sys6010 Meets Primary Endpoint Of Progression-Free Survival In Phase Iii Synstar-01 Study
CSPC Pharma climbs as FDA approves RSV vaccine clinical trials in US
Brief: CSPC Pharmaceutical Says Recombinant Respiratory Syncytial Virus Vaccine Gets Clinical Trial Approval In U.S.
Cspc Pharmaceutical Hits 6: month high on profit, dividend surge
China's CSPC Pharmaceutical H1 revenue rises on finished drug business growth
Brief: CSPC Pharmaceutical Group Declares Interim Dividend Of HK18 Cents Per Share
Brief: CSPC Pharma Says NMPA Accepts NDA For KN026 And HB1801 For Advanced Breast Cancer
Brief: CSPC Pharmaceutical Receives $30 MLN Upfront Payment From Astrazeneca Under Collaboration Agreement
Brief: CSPC Pharmaceutical Initiates Phase I Trial Of SYS6063 For Relapsed, Refractory SLE In China
CSPC Pharma climbs as mpox mRNA vaccine gets US FDA clinical trial approval
Brief: CSPC Pharmaceutical Says SYS6037 Mpox MRNA Vaccine Obtains FDA Clinical Trial Approval
Brief: CSPC Pharmaceutical And AstraZeneca Enter JV For Biologics Facility In China
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)
Brief: CSPC Pharma Initiates Phase IB/II Trial Of SYS 6090 Injection For Colorectal Cancer In China
Brief: CSPC Pharmaceutical Says Unit Enters FX Swap And FX Forward Contracts With ICBC Since June 16
Brief: Cspc Pharmaceutical Says Crb-701 Receives FDA Clearance For Registrational Trial
Cspc Innovation Pharmaceutical Rises On Upbeat First: half profit outlook
China's CSPC Pharmaceutical rises on robust H1 earnings forecast